Karagiannis George S, Pavlou Maria P, Saraon Punit, Musrap Natasha, Xie Annie, Batruch Ihor, Prassas Ioannis, Dimitromanolakis Apostolos, Petraki Constantina, Diamandis Eleftherios P
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
J Proteomics. 2014 May 30;103:121-36. doi: 10.1016/j.jprot.2014.03.018. Epub 2014 Mar 27.
Systemic mining of cancer exoproteome/secretome has emerged as a pivotal strategy for delineation of molecular pathways with mechanistic importance in cancer development, as well as the discovery of diagnostic/prognostic biomarkers. Although major advances in diagnostic and therapeutic management of colorectal cancer have been underscored in the last decade, this cancer still remains the second leading cause of cancer-related deaths in the developed world. Despite previous studies on deciphering the colorectal cancer exoproteome, such studies lack adequate depth and robustness due to technological limitations. Here, using a well-established LC-MS/MS method on an LTQ-Orbitrap mass spectrometer, we extensively delineated the exoproteome of 12 colon cancer cell lines. In total, 2979 non-redundant proteins were identified with a minimum of two peptides, of which ~62% were extracellular or cell membrane-bound, based on prediction software. To further characterize this dataset and identify clinical opportunities, first, we investigated overrepresented molecular concepts of interest via enrichment map analysis and second, we demonstrated translational importance of certain proteins, such as olfactomedin-4 and kallikrein-related peptidases-6 and -10, by investigating their expression levels in patient tissues and/or fluids. Overall, the present study details a comprehensive colorectal cancer exoproteome dataset, and may be used as future platform for biomarker discovery, and hypothesis-generating studies.
This article represents one of the most extensive and comprehensive proteomic datasets regarding the secreted/extracellular proteome of colorectal cancer cell lines. The reported datasets may form a platform for a plethora of future, discovery-based or hypothesis-generating studies, attempting to either delineate putative cancer biomarkers for CRC, or elucidate questions of mechanistic importance (e.g. investigation of deregulated pathways for CRC progression).
对癌症外泌蛋白质组/分泌蛋白质组进行系统挖掘,已成为描绘在癌症发展中具有重要机制意义的分子途径以及发现诊断/预后生物标志物的关键策略。尽管在过去十年中,结直肠癌的诊断和治疗管理取得了重大进展,但在发达国家,这种癌症仍然是癌症相关死亡的第二大主要原因。尽管之前有关于解析结直肠癌外泌蛋白质组的研究,但由于技术限制,这些研究缺乏足够的深度和稳健性。在这里,我们使用在LTQ-Orbitrap质谱仪上成熟的LC-MS/MS方法,广泛描绘了12种结肠癌细胞系的外泌蛋白质组。总共鉴定出2979种非冗余蛋白质,每种至少有两个肽段,根据预测软件,其中约62%是细胞外或细胞膜结合的。为了进一步表征这个数据集并确定临床应用机会,首先,我们通过富集图谱分析研究了感兴趣的过度表达的分子概念;其次,我们通过研究某些蛋白质(如嗅觉介质-4和激肽释放酶相关肽酶-6和-10)在患者组织和/或体液中的表达水平,证明了它们的转化重要性。总体而言,本研究详细描述了一个全面的结直肠癌外泌蛋白质组数据集,可作为未来生物标志物发现和假设生成研究的平台。
本文代表了关于结肠癌细胞系分泌/细胞外蛋白质组最广泛和全面的蛋白质组学数据集之一。所报告的数据集可能为大量未来基于发现或假设生成的研究形成一个平台,这些研究要么试图描绘结直肠癌的假定癌症生物标志物,要么阐明具有重要机制意义的问题(例如研究结直肠癌进展中失调的途径)。